LINTEX
920106
LINGOOD
833284
NTGEC
870436
CG MED EQUIP.
838810
Jiayu Holding
300117
CN Stock MarketDetailed Quotes
002772 Tianshui Zhongxing Bio-technology
- 7.08
- -0.19-2.61%
Market Closed Feb 28 15:00 CST
2.78BMarket Cap38.27P/E (TTM)
7.29High7.07Low76.36KlotVolume7.24Open7.27Pre Close54.70MTurnover1.96%Turnover Ratio17.44P/E (Static)393.24MShares9.3352wk High0.82P/B2.76BFloat Cap5.5252wk Low8.00Limit Up390.14MShs Float30.21Historical High6.54Limit Down3.03%Amplitude5.06Historical Low0.30Dividend TTM7.16Avg Price52.26KlotAsk4.24%Div YieldTTM100Lot Size22.66KlotBid
Tianshui Zhongxing Bio-technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -3.63%1.4B | -10.72%913.05M | -22.49%484.39M | -0.89%1.93B | 2.07%1.46B | 21.87%1.02B | 34.18%624.92M | 24.43%1.94B | 35.26%1.43B | 20.10%839.16M |
| Refunds of taxes and levies | ---- | ---- | --180.85K | ---- | ---- | ---- | ---- | --15.92K | --15.92K | --15.92K |
| Cash received relating to other operating activities | -3.64%50.03M | -3.30%31.79M | -0.96%14.97M | -3.06%78.31M | -9.00%51.91M | -2.44%32.88M | -17.47%15.12M | -19.58%80.78M | -17.81%57.05M | -18.17%33.7M |
| Cash inflows from operating activities | -3.63%1.45B | -10.49%944.84M | -21.95%499.55M | -0.98%2.01B | 1.64%1.51B | 20.92%1.06B | 32.23%640.04M | 21.77%2.03B | 31.98%1.48B | 17.97%872.88M |
| Goods services cash paid | 1.06%834.86M | 2.37%543.31M | 5.19%271.23M | -3.17%1.12B | -3.84%826.14M | -4.29%530.71M | -0.88%257.85M | -34.13%1.15B | 18.19%859.1M | 19.81%554.49M |
| Staff behalf paid | 7.53%288.12M | 10.14%203.22M | 13.31%120.31M | 4.17%353.89M | 4.10%267.94M | 7.45%184.51M | 27.36%106.18M | 17.01%339.73M | 18.57%257.39M | 11.02%171.72M |
| All taxes paid | 33.63%3.44M | 14.97%2.24M | -10.12%993.37K | 2.91%2.88M | 22.49%2.57M | 27.54%1.95M | 41.11%1.11M | 19.88%2.8M | -36.33%2.1M | -9.68%1.53M |
| Cash paid relating to other operating activities | 5.35%24.18M | 19.05%15.27M | -46.30%7.09M | -17.38%29.8M | 12.72%22.95M | 10.47%12.82M | 15.95%13.21M | 6.39%36.07M | -17.71%20.36M | -3.78%11.61M |
| Cash outflows from operating activities | 2.77%1.15B | 4.66%764.04M | 5.63%399.64M | -1.86%1.5B | -1.70%1.12B | -1.27%729.99M | 6.37%378.34M | -26.26%1.53B | 17.17%1.14B | 17.12%739.35M |
| Net cash flows from operating activities | -22.11%301.78M | -44.46%180.8M | -61.82%99.91M | 1.78%502.48M | 12.72%387.42M | 143.79%325.54M | 103.90%261.7M | 219.34%493.7M | 127.09%343.7M | 22.91%133.53M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -43.87%168.38M | -43.87%168.38M | 0.00%50M | -61.21%450M | -57.14%300M | 3.40%300M | -50.99%50M | 23.01%1.16B | -11.25%700M | --290.14M |
| Cash received from returns on investments | -44.91%8.74M | -36.17%8.74M | 105.03%1.26M | 76.63%22.02M | 119.14%15.87M | 533.64%13.69M | 12.05%615.63K | -24.20%12.47M | -52.31%7.24M | -82.39%2.16M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 5,555.48%1.8M | 3,497.10%898.7K | -30.34%1.38K | -98.94%31.88K | -98.94%31.88K | -99.17%24.98K | -99.93%1.98K | 668.55%3M | --3M | --3M |
| Cash inflows from investing activities | -43.36%178.93M | -43.25%178.02M | 1.28%51.26M | -59.84%472.06M | -55.52%315.9M | 6.24%313.72M | -52.05%50.62M | 22.37%1.18B | -11.65%710.24M | -50.39%295.3M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 137.67%160.52M | 130.21%111.35M | 182.64%82.25M | -56.48%107M | -61.57%67.54M | -64.69%48.37M | -50.22%29.1M | -14.18%245.86M | -75.53%175.77M | -63.54%136.98M |
| Cash paid to acquire investments | -45.16%175.5M | -49.88%160.4M | ---- | -69.47%400M | -72.41%320M | -56.16%320M | ---- | 156.86%1.31B | 251.52%1.16B | --730M |
| Cash outflows from investing activities | -13.29%336.02M | -26.23%271.75M | 182.64%82.25M | -67.41%507M | -70.99%387.54M | -57.51%368.37M | -90.25%29.1M | 95.34%1.56B | 27.43%1.34B | 22.84%866.98M |
| Net cash flows from investing activities | -119.29%-157.1M | -71.51%-93.73M | -243.99%-30.98M | 90.81%-34.94M | 88.55%-71.64M | 90.44%-54.65M | 111.16%21.52M | -331.81%-380.39M | -155.99%-625.52M | -417.42%-571.68M |
| Financing cash flow | ||||||||||
| Cash from borrowing | 66.26%1.32B | 59.35%1.11B | 51.31%749M | -38.40%815M | -31.64%795M | -30.01%695M | 54.21%495M | -9.36%1.32B | -6.47%1.16B | 14.20%993M |
| Cash inflows from financing activities | 66.26%1.32B | 59.35%1.11B | 51.31%749M | -38.40%815M | -31.64%795M | -30.01%695M | 54.21%495M | -9.36%1.32B | -6.47%1.16B | 14.20%993M |
| Borrowing repayment | 76.48%966.86M | 104.24%838.61M | 246.09%243.65M | -10.60%1.36B | -45.15%547.85M | -43.25%410.61M | -41.58%70.4M | 123.34%1.52B | 83.03%998.84M | 74.72%723.54M |
| Dividend interest payment | -4.76%179.52M | -3.49%159.45M | 420.15%95.22M | 23.76%210.79M | 52.64%188.5M | 69.80%165.21M | -36.62%18.31M | 14.57%170.32M | 5.13%123.49M | 7.07%97.3M |
| Cash payments relating to other financing activities | ---- | ---- | ---- | 0.00%24.04K | ---- | ---- | ---- | --24.04K | ---- | ---- |
| Cash outflows from financing activities | 55.68%1.15B | 73.33%998.06M | 282.01%338.87M | -7.14%1.57B | -34.39%736.35M | -29.85%575.82M | -40.62%88.71M | 103.85%1.69B | 69.23%1.12B | 62.54%820.84M |
| Net cash flows from financing activities | 199.04%175.39M | -8.16%109.45M | 0.94%410.13M | -105.25%-755.2M | 44.22%58.65M | -30.77%119.18M | 136.74%406.29M | -158.39%-367.93M | -92.99%40.67M | -52.77%172.16M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | --4.13K | ---4.91K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net increase in cash and cash equivalents | -14.52%320.08M | -49.62%196.52M | -30.52%479.06M | -12.98%-287.66M | 255.27%374.44M | 246.64%390.07M | 543.89%689.51M | -166.91%-254.62M | -149.49%-241.16M | -173.35%-266M |
| Add:Begin period cash and cash equivalents | -21.69%1.04B | -21.69%1.04B | -21.69%1.04B | -16.11%1.33B | -16.11%1.33B | -16.11%1.33B | -16.11%1.33B | 31.71%1.58B | 31.71%1.58B | 31.71%1.58B |
| End period cash equivalent | -20.11%1.36B | -28.04%1.24B | -24.71%1.52B | -21.69%1.04B | 26.95%1.7B | 30.53%1.72B | 19.42%2.02B | -16.11%1.33B | -20.62%1.34B | -15.87%1.31B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
